Skip to main content

Featured

Trump Pressures Tehran as Calls for Negotiations Intensify

  esident Donald Trump speaks with reporters during the swearing in ceremony for Homeland Security Secretary Markwayne Mullin in the Oval Office of the White House, Tuesday, March 24, 2026, in Washington. President Donald Trump has issued a stark warning to Iran, urging its leaders to engage in negotiations “before it is too late,” as military tensions continue to rise across the region. His remarks, delivered via social media, emphasized that Iran faces severe consequences if it refuses to pursue a peace agreement.  The warning comes amid ongoing U.S. and Israeli military operations targeting Iranian infrastructure and leadership figures. Despite Washington’s insistence that indirect talks are underway, Tehran publicly denies any formal negotiations, insisting it is merely reviewing proposals relayed through intermediaries.  Trump described Iranian negotiators as “strange” and claimed they were “begging” for a deal behind the scenes while rejecting U.S. terms in publi...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment